Clinical Trials, Latest News, Medical Research

ARHI Representatives Join Eli Lilly GZMG Investigator Engagement Meeting to Advance Opioid Use Disorder Clinical Research

ARHI Social Media Logo | Clinical Trials for Advanced Research for Health Improvement

Naples, FL — [March 04th,2026] — Advanced Research for Health Improvement (ARHI) is proud to announce that our Principal Investigator Dr. Leonard Lado and Clinical Trials Manager Juan C. Ramos, M.S. participated in the Eli Lilly GZMG Investigator Engagement Meeting on March 23rd and 24th, 2026, in Atlanta, GA, focused on the upcoming Opioid Use Disorder (OUD) clinical trial sponsored by Eli Lilly and Company.

The Investigator Engagement Meeting brought together leading clinical investigators, research coordinators, and sponsor representatives to discuss key elements of trial design, operational execution, and participant engagement strategies for an innovative OUD study currently being developed. Although study details are being finalized, the trial is part of ongoing efforts within the scientific and medical community to develop new therapeutic approaches for opioid dependence and addiction.

Dr. Leonard Lado and Juan C. Ramos, M.S., representing ARHI at the Eli Lilly GZMG Investigator Engagement Meeting, March 23–24, 2026.

Photo: Dr. Leonard Lado and Juan C. Ramos, M.S., representing ARHI at the Eli Lilly GZMG Investigator Engagement Meeting, March 23–24, 2026.

Participation in this meeting provided ARHI leadership with important insights into the upcoming clinical trial protocol, regulatory requirements, and multi-site coordination practices. Engaging directly with the Eli Lilly team and fellow investigators ensured that ARHI remains aligned with advancing standards in clinical research and patient-centric trial conduct.

“Engaging with sponsors like Eli Lilly on early clinical trial planning underscores our commitment to research excellence and collaboration,” said Dr. Leonard Lado, Principal Investigator at ARHI. “The discussions we had will strengthen how we approach clinical rigor, participant safety, and scientific integrity in future opioid use disorder research.”

ARHI continues to expand its involvement in multi-center clinical research across therapeutic areas, with a focus on high-impact diseases and conditions where innovation can translate into meaningful patient benefit.

About ARHI
Advanced Research for Health Improvement (ARHI) is a clinical research organization dedicated to conducting rigorous medical research and fostering evidence-based innovation that improves health outcomes. Our team collaborates with academic partners, pharmaceutical sponsors, and community stakeholders to support advancing clinical science across diverse therapeutic areas.

Follow Us:
Website: arhiusa.com
LinkedIn • Facebook • Twitter/X • Instagram

Media Contact:
Juan C. Ramos, M.S
Managing Partner | ARHI
[239-230-2021] • [info@arhiusa.com]
[www.arhiusa.com]